Form EFFECT Nasus Pharma Ltd
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 13, 2026 4:30 P.M. |
| Form: | F-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
- Sungrow Showcases All-Star Renewable Energy Solutions at Intersolar Europe 2026
- Form 8.3 - [ANIMALCARE GROUP PLC - 24 06 2026] - (CGWL)
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
